Search Results 1071-1080 of 15858 for syphilis
Learn how Dr. Ling's Phospholipid Signaling in Embryonic Development and Human Diseases Lab at Mayo Clinic studies the roles of phosphoinositide species and ...
The purpose of this study is to determine if study drug (BMS-986020) dose of 600 mg once daily or 600 mg twice daily for 26 weeks compared with placebo will ...
Learn how Mayo Clinic's Division of Clinical Trials and Biostatistics provides high-value analytical collaborations and research services to investigators.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Belinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as guadecitabine, work in ...
The main purpose of this study is to evaluate the effectiveness of IONIS-TMPRSS6-LRx in reducing the frequency of phlebotomy and in improving quality of life ...
About this study. The primary aim of this study is to use an MRI-based Muscle Assessment Score (MAsS), which includes both muscle volume and fat ...
Ruxolitinib phosphate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Participation eligibility. Participant ...
Centers and Programs Center for Clinical and Translational Science (CCaTS) Education Overview Education Education Overview Certificate Program Clinical Trialist ...
Roston TM, Aghanya V, Savu A, Fordyce CB, Lawler PR, Jentzer J, Wong GC, Brunham LR, Senaratne J, van Diepen S, Kaul P. Premature Acute Myocardial ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.